Accessibility, Instruction, and Media (AIM) Specialist
Plattsburgh, NY (On-site)
Posted 2 months ago
Top 1% of applicants do these two things.
The other 99% submit and hope. You're about to do something different.
Job Description
Working within IPI offers the opportunity to contribute to meaningful academic initiatives that support faculty success and student learning. Team members engage with evolving instructional technologies, inclusive teaching strategies, and innovative program development, helping to shape how education is delivered in a dynamic higher education environment.
The Center reflects the University’s commitment to continuous improvement, collaboration, and effectiveness in teaching and learning. It partners with faculty and academic departments to advance high-quality, accessible, and forward-looking instruction. It also brings together instructional technology support, faculty development, accessibility guidance, and online course and program design within a collaborative framework that strengthens instructional practices across the University. As SUNY Plattsburgh is an institution that delivers challenging and high-quality educational experiences to a diverse group of learners, the successful candidate must demonstrate an understanding of and sensitivity to diversity, inclusion, and equity-minded policies, programs, and practices.
Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years.Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.
